<?xml version="1.0" encoding="UTF-8"?>
<OAI-PMH xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd">
  <responseDate>2024-05-03T11:16:32Z</responseDate>
  <request verb="GetRecord" identifier="oai:pubmedcentral.nih.gov:5753815" metadataPrefix="pmc">https:/www.ncbi.nlm.nih.gov/pmc/oai/oai.cgi</request>
  <GetRecord>
    <record>
      <header>
        <identifier>oai:pubmedcentral.nih.gov:5753815</identifier>
        <datestamp>2018-01-31</datestamp>
        <setSpec>lwwopen</setSpec>
        <setSpec>pmc-open</setSpec>
      </header>
      <metadata>
        <article xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xsi:schemaLocation="https://jats.nlm.nih.gov/ns/archiving/1.3/ https://jats.nlm.nih.gov/archiving/1.3/xsd/JATS-archivearticle1-3.xsd" article-type="research-article">
          <front>
            <journal-meta>
              <journal-id journal-id-type="nlm-ta">Stroke</journal-id>
              <journal-id journal-id-type="iso-abbrev">Stroke</journal-id>
              <journal-id journal-id-type="publisher-id">STR</journal-id>
              <journal-title-group>
                <journal-title>Stroke</journal-title>
              </journal-title-group>
              <issn pub-type="ppub">0039-2499</issn>
              <issn pub-type="epub">1524-4628</issn>
              <publisher>
                <publisher-name>Lippincott Williams &amp; Wilkins</publisher-name>
              </publisher>
            </journal-meta>
            <article-meta>
              <article-id pub-id-type="accession">PMC5753815</article-id>
              <article-id pub-id-type="pmcid">PMC5753815</article-id>
              <article-id pub-id-type="pmc-uid">5753815</article-id>
              <article-id pub-id-type="pmid">29247143</article-id>
              <article-id pub-id-type="art-access-id">00008</article-id>
              <article-id pub-id-type="doi">10.1161/STROKEAHA.117.019409</article-id>
              <article-categories>
                <subj-group subj-group-type="hwp-journal-coll">
                  <subject>10173</subject>
                  <subject>10176</subject>
                  <subject>10177</subject>
                </subj-group>
                <subj-group subj-group-type="heading">
                  <subject>Original Contributions</subject>
                  <subj-group>
                    <subject>Clinical Sciences</subject>
                  </subj-group>
                </subj-group>
              </article-categories>
              <title-group>
                <article-title>Cognitive Impairment Before Intracerebral Hemorrhage Is Associated With Cerebral Amyloid Angiopathy</article-title>
              </title-group>
              <contrib-group>
                <contrib contrib-type="author">
                  <name>
                    <surname>Banerjee</surname>
                    <given-names>Gargi</given-names>
                  </name>
                  <degrees>BMBCh, MRCP</degrees>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Wilson</surname>
                    <given-names>Duncan</given-names>
                  </name>
                  <degrees>MBChB</degrees>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Ambler</surname>
                    <given-names>Gareth</given-names>
                  </name>
                  <degrees>PhD</degrees>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Osei-Bonsu Appiah</surname>
                    <given-names>Karen</given-names>
                  </name>
                  <degrees>MSc</degrees>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Shakeshaft</surname>
                    <given-names>Clare</given-names>
                  </name>
                  <degrees>MSc</degrees>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Lunawat</surname>
                    <given-names>Surabhika</given-names>
                  </name>
                  <degrees>MSc</degrees>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Cohen</surname>
                    <given-names>Hannah</given-names>
                  </name>
                  <degrees>PhD</degrees>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Yousry</surname>
                    <given-names>Tarek</given-names>
                    <suffix>Dr</suffix>
                  </name>
                  <degrees>Med Habil</degrees>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Lip</surname>
                    <given-names>Gregory Y.H.</given-names>
                  </name>
                  <degrees>FRCP</degrees>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Muir</surname>
                    <given-names>Keith W.</given-names>
                  </name>
                  <degrees>MD</degrees>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Brown</surname>
                    <given-names>Martin M.</given-names>
                  </name>
                  <degrees>FRCP</degrees>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Al-Shahi Salman</surname>
                    <given-names>Rustam</given-names>
                  </name>
                  <degrees>PhD</degrees>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>JÃ¤ger</surname>
                    <given-names>Hans Rolf</given-names>
                  </name>
                  <degrees>MD</degrees>
                </contrib>
                <contrib contrib-type="author" corresp="yes">
                  <name>
                    <surname>Werring</surname>
                    <given-names>David J.</given-names>
                  </name>
                  <degrees>PhD</degrees>
                </contrib>
                <on-behalf-of>on behalf of the CROMIS-2 Collaborators</on-behalf-of>
                <xref ref-type="fn" rid="fn02">*</xref>
                <aff>From the UCL Stroke Research Centre (G.B., D.W., K.O.-B.A., C.S., S.L., M.M.B., D.J.W.) and Lysholm Department of Neuroradiology and the Neuroradiological Academic Unit (T.Y., H.R.J.), Department of Brain Repair and Rehabilitation, UCL Institute of Neurology, and the National Hospital for Neurology and Neurosurgery, London, United Kingdom; Department of Statistical Science (G.A.) and Haemostasis Research Unit, Department of Haematology (H.C.), University College London, United Kingdom; University of Birmingham Institute of Cardiovascular Sciences, City Hospital, United Kingdom (G.Y.H.L.); Institute of Neuroscience &amp; Psychology, University of Glasgow, Queen Elizabeth University Hospital, United Kingdom (K.W.M.); and Centre for Clinical Brain Sciences, School of Clinical Sciences, University of Edinburgh, United Kingdom (R.A.-S.S.).</aff>
              </contrib-group>
              <contrib-group content-type="collaborators">
                <contrib contrib-type="collab">
                  <name>
                    <surname>Shaw</surname>
                    <given-names>Louise</given-names>
                  </name>
                  <degrees>MD</degrees>
                </contrib>
                <contrib contrib-type="collab">
                  <name>
                    <surname>Sword</surname>
                    <given-names>Jane</given-names>
                  </name>
                  <degrees>MD</degrees>
                </contrib>
                <contrib contrib-type="collab">
                  <name>
                    <surname>Mohd Nor</surname>
                    <given-names>Azlisham</given-names>
                  </name>
                  <degrees>MD</degrees>
                </contrib>
                <contrib contrib-type="collab">
                  <name>
                    <surname>Sharma</surname>
                    <given-names>Pankaj</given-names>
                  </name>
                  <degrees>PhD</degrees>
                </contrib>
                <contrib contrib-type="collab">
                  <name>
                    <surname>Veltkamp</surname>
                    <given-names>Roland</given-names>
                  </name>
                  <degrees>MD</degrees>
                </contrib>
                <contrib contrib-type="collab">
                  <name>
                    <surname>Kelly</surname>
                    <given-names>Deborah</given-names>
                  </name>
                  <degrees>MD</degrees>
                </contrib>
                <contrib contrib-type="collab">
                  <name>
                    <surname>Harrington</surname>
                    <given-names>Frances</given-names>
                  </name>
                  <degrees>MD</degrees>
                </contrib>
                <contrib contrib-type="collab">
                  <name>
                    <surname>Randall</surname>
                    <given-names>Marc</given-names>
                  </name>
                  <degrees>MD</degrees>
                </contrib>
                <contrib contrib-type="collab">
                  <name>
                    <surname>Smith</surname>
                    <given-names>Matthew</given-names>
                  </name>
                  <degrees>MD</degrees>
                </contrib>
                <contrib contrib-type="collab">
                  <name>
                    <surname>Mahawish</surname>
                    <given-names>Karim</given-names>
                  </name>
                  <degrees>MD</degrees>
                </contrib>
                <contrib contrib-type="collab">
                  <name>
                    <surname>Elmarim</surname>
                    <given-names>Abduelbaset</given-names>
                  </name>
                  <degrees>MD</degrees>
                </contrib>
                <contrib contrib-type="collab">
                  <name>
                    <surname>Esisi</surname>
                    <given-names>Bernard</given-names>
                  </name>
                  <degrees>MD</degrees>
                </contrib>
                <contrib contrib-type="collab">
                  <name>
                    <surname>Cullen</surname>
                    <given-names>Claire</given-names>
                  </name>
                  <degrees>MD</degrees>
                </contrib>
                <contrib contrib-type="collab">
                  <name>
                    <surname>Nallasivam</surname>
                    <given-names>Arumug</given-names>
                  </name>
                  <degrees>MD</degrees>
                </contrib>
                <contrib contrib-type="collab">
                  <name>
                    <surname>Price</surname>
                    <given-names>Christopher</given-names>
                  </name>
                  <degrees>MD</degrees>
                </contrib>
                <contrib contrib-type="collab">
                  <name>
                    <surname>Barry</surname>
                    <given-names>Adrian</given-names>
                  </name>
                  <degrees>MD</degrees>
                </contrib>
                <contrib contrib-type="collab">
                  <name>
                    <surname>Roffe</surname>
                    <given-names>Christine</given-names>
                  </name>
                  <degrees>MD</degrees>
                </contrib>
                <contrib contrib-type="collab">
                  <name>
                    <surname>Coyle</surname>
                    <given-names>John</given-names>
                  </name>
                  <degrees>MD</degrees>
                </contrib>
                <contrib contrib-type="collab">
                  <name>
                    <surname>Hassan</surname>
                    <given-names>Ahamad</given-names>
                  </name>
                  <degrees>MD</degrees>
                </contrib>
                <contrib contrib-type="collab">
                  <name>
                    <surname>Lovelock</surname>
                    <given-names>Caroline</given-names>
                  </name>
                  <degrees>DPhil</degrees>
                </contrib>
                <contrib contrib-type="collab">
                  <name>
                    <surname>Birns</surname>
                    <given-names>Jonathan</given-names>
                  </name>
                  <degrees>MD</degrees>
                </contrib>
                <contrib contrib-type="collab">
                  <name>
                    <surname>Cohen</surname>
                    <given-names>David</given-names>
                  </name>
                  <degrees>MD</degrees>
                </contrib>
                <contrib contrib-type="collab">
                  <name>
                    <surname>Sekaran</surname>
                    <given-names>L.</given-names>
                  </name>
                  <degrees>MD</degrees>
                </contrib>
                <contrib contrib-type="collab">
                  <name>
                    <surname>Parry-Jones</surname>
                    <given-names>Adrian</given-names>
                  </name>
                  <degrees>PhD</degrees>
                </contrib>
                <contrib contrib-type="collab">
                  <name>
                    <surname>Parry</surname>
                    <given-names>Anthea</given-names>
                  </name>
                  <degrees>MD</degrees>
                </contrib>
                <contrib contrib-type="collab">
                  <name>
                    <surname>Hargroves</surname>
                    <given-names>David</given-names>
                  </name>
                  <degrees>MD</degrees>
                </contrib>
                <contrib contrib-type="collab">
                  <name>
                    <surname>Proschel</surname>
                    <given-names>Harald</given-names>
                  </name>
                  <degrees>MD</degrees>
                </contrib>
                <contrib contrib-type="collab">
                  <name>
                    <surname>Datta</surname>
                    <given-names>Prabel</given-names>
                  </name>
                  <degrees>MD</degrees>
                </contrib>
                <contrib contrib-type="collab">
                  <name>
                    <surname>Darawil</surname>
                    <given-names>Khaled</given-names>
                  </name>
                  <degrees>MD</degrees>
                </contrib>
                <contrib contrib-type="collab">
                  <name>
                    <surname>Manoj</surname>
                    <given-names>Aravindakshan</given-names>
                  </name>
                  <degrees>MD</degrees>
                </contrib>
                <contrib contrib-type="collab">
                  <name>
                    <surname>Burn</surname>
                    <given-names>Mathew</given-names>
                  </name>
                  <degrees>MD</degrees>
                </contrib>
                <contrib contrib-type="collab">
                  <name>
                    <surname>Patterson</surname>
                    <given-names>Chris</given-names>
                  </name>
                  <degrees>MD</degrees>
                </contrib>
                <contrib contrib-type="collab">
                  <name>
                    <surname>Giallombardo</surname>
                    <given-names>Elio</given-names>
                  </name>
                  <degrees>MD</degrees>
                </contrib>
                <contrib contrib-type="collab">
                  <name>
                    <surname>Smyth</surname>
                    <given-names>Nigel</given-names>
                  </name>
                  <degrees>MD</degrees>
                </contrib>
                <contrib contrib-type="collab">
                  <name>
                    <surname>Mansoor</surname>
                    <given-names>Syed</given-names>
                  </name>
                  <degrees>MD</degrees>
                </contrib>
                <contrib contrib-type="collab">
                  <name>
                    <surname>Anwar</surname>
                    <given-names>Ijaz</given-names>
                  </name>
                  <degrees>MD</degrees>
                </contrib>
                <contrib contrib-type="collab">
                  <name>
                    <surname>Marsh</surname>
                    <given-names>Rachel</given-names>
                  </name>
                  <degrees>MD</degrees>
                </contrib>
                <contrib contrib-type="collab">
                  <name>
                    <surname>Ispoglou</surname>
                    <given-names>Sissi</given-names>
                  </name>
                  <degrees>MD</degrees>
                </contrib>
                <contrib contrib-type="collab">
                  <name>
                    <surname>Chadha</surname>
                    <given-names>Dinesh</given-names>
                  </name>
                  <degrees>MD</degrees>
                </contrib>
                <contrib contrib-type="collab">
                  <name>
                    <surname>Prabhakaran</surname>
                    <given-names>Mathuri</given-names>
                  </name>
                  <degrees>MD</degrees>
                </contrib>
                <contrib contrib-type="collab">
                  <name>
                    <surname>Meenakishundaram</surname>
                    <given-names>Sanjeevikumar</given-names>
                  </name>
                  <degrees>MD</degrees>
                </contrib>
                <contrib contrib-type="collab">
                  <name>
                    <surname>OâConnell</surname>
                    <given-names>Janice</given-names>
                  </name>
                  <degrees>MD</degrees>
                </contrib>
                <contrib contrib-type="collab">
                  <name>
                    <surname>Scott</surname>
                    <given-names>Jon</given-names>
                  </name>
                  <degrees>MD</degrees>
                </contrib>
                <contrib contrib-type="collab">
                  <name>
                    <surname>Krishnamurthy</surname>
                    <given-names>Vinodh</given-names>
                  </name>
                  <degrees>MD</degrees>
                </contrib>
                <contrib contrib-type="collab">
                  <name>
                    <surname>Aghoram</surname>
                    <given-names>Prasanna</given-names>
                  </name>
                  <degrees>MD</degrees>
                </contrib>
                <contrib contrib-type="collab">
                  <name>
                    <surname>McCormick</surname>
                    <given-names>Michael</given-names>
                  </name>
                  <degrees>MD</degrees>
                </contrib>
                <contrib contrib-type="collab">
                  <name>
                    <surname>OâMahony</surname>
                    <given-names>Paul</given-names>
                  </name>
                  <degrees>MD</degrees>
                </contrib>
                <contrib contrib-type="collab">
                  <name>
                    <surname>Cooper</surname>
                    <given-names>Martin</given-names>
                  </name>
                  <degrees>MD</degrees>
                </contrib>
                <contrib contrib-type="collab">
                  <name>
                    <surname>Choy</surname>
                    <given-names>Lillian</given-names>
                  </name>
                  <degrees>MD</degrees>
                </contrib>
                <contrib contrib-type="collab">
                  <name>
                    <surname>Wilkinson</surname>
                    <given-names>Peter</given-names>
                  </name>
                  <degrees>MD</degrees>
                </contrib>
                <contrib contrib-type="collab">
                  <name>
                    <surname>Leach</surname>
                    <given-names>Simon</given-names>
                  </name>
                  <degrees>MD</degrees>
                </contrib>
                <contrib contrib-type="collab">
                  <name>
                    <surname>Caine</surname>
                    <given-names>Sarah</given-names>
                  </name>
                  <degrees>MD</degrees>
                </contrib>
                <contrib contrib-type="collab">
                  <name>
                    <surname>Burger</surname>
                    <given-names>Ilse</given-names>
                  </name>
                  <degrees>MD</degrees>
                </contrib>
                <contrib contrib-type="collab">
                  <name>
                    <surname>Gunathilagan</surname>
                    <given-names>Gunaratam</given-names>
                  </name>
                  <degrees>MD</degrees>
                </contrib>
                <contrib contrib-type="collab">
                  <name>
                    <surname>Guyler</surname>
                    <given-names>Paul</given-names>
                  </name>
                  <degrees>MD</degrees>
                </contrib>
                <contrib contrib-type="collab">
                  <name>
                    <surname>Emsley</surname>
                    <given-names>Hedley</given-names>
                  </name>
                  <degrees>MD</degrees>
                </contrib>
                <contrib contrib-type="collab">
                  <name>
                    <surname>Davis</surname>
                    <given-names>Michelle</given-names>
                  </name>
                  <degrees>MD</degrees>
                </contrib>
                <contrib contrib-type="collab">
                  <name>
                    <surname>Manawadu</surname>
                    <given-names>Dulka</given-names>
                  </name>
                  <degrees>MD</degrees>
                </contrib>
                <contrib contrib-type="collab">
                  <name>
                    <surname>Pasco</surname>
                    <given-names>Kath</given-names>
                  </name>
                  <degrees>MD</degrees>
                </contrib>
                <contrib contrib-type="collab">
                  <name>
                    <surname>Mamun</surname>
                    <given-names>Maam</given-names>
                  </name>
                  <degrees>MD</degrees>
                </contrib>
                <contrib contrib-type="collab">
                  <name>
                    <surname>Luder</surname>
                    <given-names>Robert</given-names>
                  </name>
                  <degrees>MD</degrees>
                </contrib>
                <contrib contrib-type="collab">
                  <name>
                    <surname>Sajid</surname>
                    <given-names>Mahmud</given-names>
                  </name>
                  <degrees>MD</degrees>
                </contrib>
                <contrib contrib-type="collab">
                  <name>
                    <surname>Anwar</surname>
                    <given-names>Ijaz</given-names>
                  </name>
                  <degrees>MD</degrees>
                </contrib>
                <contrib contrib-type="collab">
                  <name>
                    <surname>Okwera</surname>
                    <given-names>James</given-names>
                  </name>
                  <degrees>MD</degrees>
                </contrib>
                <contrib contrib-type="collab">
                  <name>
                    <surname>Staals</surname>
                    <given-names>Julie</given-names>
                  </name>
                  <degrees>PhD</degrees>
                </contrib>
                <contrib contrib-type="collab">
                  <name>
                    <surname>Warburton</surname>
                    <given-names>Elizabeth</given-names>
                  </name>
                  <degrees>MD</degrees>
                </contrib>
                <contrib contrib-type="collab">
                  <name>
                    <surname>Saastamoinen</surname>
                    <given-names>Kari</given-names>
                  </name>
                  <degrees>MD</degrees>
                </contrib>
                <contrib contrib-type="collab">
                  <name>
                    <surname>England</surname>
                    <given-names>Timothy</given-names>
                  </name>
                  <degrees>MD</degrees>
                </contrib>
                <contrib contrib-type="collab">
                  <name>
                    <surname>Putterill</surname>
                    <given-names>Janet</given-names>
                  </name>
                  <degrees>MD</degrees>
                </contrib>
                <contrib contrib-type="collab">
                  <name>
                    <surname>Flossman</surname>
                    <given-names>Enrico</given-names>
                  </name>
                  <degrees>MD</degrees>
                </contrib>
                <contrib contrib-type="collab">
                  <name>
                    <surname>Power</surname>
                    <given-names>Michael</given-names>
                  </name>
                  <degrees>MD</degrees>
                </contrib>
                <contrib contrib-type="collab">
                  <name>
                    <surname>Dani</surname>
                    <given-names>Krishna</given-names>
                  </name>
                  <degrees>MD</degrees>
                </contrib>
                <contrib contrib-type="collab">
                  <name>
                    <surname>Mangion</surname>
                    <given-names>David</given-names>
                  </name>
                  <degrees>MD</degrees>
                </contrib>
                <contrib contrib-type="collab">
                  <name>
                    <surname>Suman</surname>
                    <given-names>Appu</given-names>
                  </name>
                  <degrees>MD</degrees>
                </contrib>
                <contrib contrib-type="collab">
                  <name>
                    <surname>Corrigan</surname>
                    <given-names>John</given-names>
                  </name>
                  <degrees>MD</degrees>
                </contrib>
                <contrib contrib-type="collab">
                  <name>
                    <surname>Lawrence</surname>
                    <given-names>Enas</given-names>
                  </name>
                  <degrees>MD</degrees>
                </contrib>
                <contrib contrib-type="collab">
                  <name>
                    <surname>Vahidassr</surname>
                    <given-names>Djamil</given-names>
                  </name>
                  <degrees>MD</degrees>
                </contrib>
              </contrib-group>
              <author-notes>
                <corresp id="c1">Correspondence to David J. Werring, PhD, FRCP, UCL Stroke Research Centre, Department of Brain Repair and Rehabilitation, UCL Institute of Neurology, Russell Sq House, 10-12 Russell Sq, London WC1B 5EH, United Kingdom. E-mail <email xlink:href="d.werring@ucl.ac.uk">d.werring@ucl.ac.uk</email></corresp>
              </author-notes>
              <pub-date pub-type="ppub">
                <month>1</month>
                <year>2018</year>
              </pub-date>
              <pub-date pub-type="epub">
                <day>15</day>
                <month>12</month>
                <year>2017</year>
              </pub-date>
              <volume>49</volume>
              <issue>1</issue>
              <fpage>40</fpage>
              <lpage>45</lpage>
              <history>
                <date date-type="received">
                  <day>12</day>
                  <month>9</month>
                  <year>2017</year>
                </date>
                <date date-type="rev-recd">
                  <day>23</day>
                  <month>10</month>
                  <year>2017</year>
                </date>
                <date date-type="accepted">
                  <day>27</day>
                  <month>10</month>
                  <year>2017</year>
                </date>
              </history>
              <permissions>
                <copyright-statement>Â© 2017 The Authors.</copyright-statement>
                <copyright-year>2017</copyright-year>
                <license license-type="open-access">
                  <license-p><italic>Stroke</italic> is published on behalf of the American Heart Association, Inc., by Wolters Kluwer Health, Inc. This is an open access article under the terms of the <ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution</ext-link> License, which permits use, distribution, and reproduction in any medium, provided that the original work is properly cited.</license-p>
                </license>
              </permissions>
              <self-uri xlink:type="simple" xlink:href="str-49-040.pdf"/>
              <abstract abstract-type="toc">
                <p>Supplemental Digital Content is available in the text.</p>
              </abstract>
              <abstract>
                <sec>
                  <title>Background and Purposeâ</title>
                  <p>Although the association between cerebral amyloid angiopathy (CAA) and cognitive impairment is increasingly recognized, it is not clear whether this is because of the impact of recurrent intracerebral hemorrhage (ICH) events, disruptions caused by cerebral small vessel damage, or both. We investigated this by considering whether cognitive impairment before ICH was associated with neuroimaging features of CAA on magnetic resonance imaging.</p>
                </sec>
                <sec>
                  <title>Methodsâ</title>
                  <p>We studied 166 patients with neuroimaging-confirmed ICH recruited to a prospective multicentre observational study. Preexisting cognitive impairment was determined using the Informant Questionnaire on Cognitive Decline in the Elderly (IQCODE). Magnetic resonance imaging markers of cerebral small vessel disease, including CAA, were rated by trained observers according to consensus guidelines.</p>
                </sec>
                <sec>
                  <title>Resultsâ</title>
                  <p>The prevalence of cognitive impairment before ICH was 24.7% (n=41) and, in adjusted analyses, was associated with fulfilling the modified Boston criteria for probable CAA at presentation (odds ratio, 4.01; 95% confidence interval, 1.53â10.51; <italic>P</italic>=0.005) and a higher composite CAA score (for each point increase, odds ratio, 1.42; 95% confidence interval, 1.03â1.97; <italic>P</italic>=0.033). We also found independent associations between pre-ICH cognitive decline and the presence of cortical superficial siderosis, strictly lobar microbleeds, and lobar ICH location, but not with other neuroimaging markers, or a composite small vessel disease score.</p>
                </sec>
                <sec>
                  <title>Conclusionsâ</title>
                  <p>CAA (defined using magnetic resonance imaging markers) is associated with cognitive decline before symptomatic ICH. This provides evidence that small vessel disruption in CAA makes an independent contribution to cognitive impairment, in addition to effects due to brain injury caused directly by ICH.</p>
                </sec>
                <sec>
                  <title>Clinical Trial Registrationâ</title>
                  <p>URL: <ext-link ext-link-type="uri" xlink:href="https://www.clinicaltrials.gov">https://www.clinicaltrials.gov</ext-link>. Unique identifier: NCT02513316.</p>
                </sec>
              </abstract>
              <kwd-group>
                <kwd>cerebral amyloid angiopathy</kwd>
                <kwd>cerebral hemorrhage</kwd>
                <kwd>cerebral small vessel diseases</kwd>
                <kwd>cognitive dysfunction</kwd>
                <kwd>prevalence</kwd>
                <kwd>siderosis</kwd>
              </kwd-group>
              <custom-meta-group>
                <custom-meta>
                  <meta-name>CME</meta-name>
                  <meta-value>CME</meta-value>
                </custom-meta>
                <custom-meta>
                  <meta-name>OPEN-ACCESS</meta-name>
                  <meta-value>TRUE</meta-value>
                </custom-meta>
              </custom-meta-group>
            </article-meta>
          </front>
          <body>
            <p>Although the associations between dementia and ischemic stroke have been comprehensively described,<sup><xref rid="R1" ref-type="bibr">1</xref></sup> fewer data are available for spontaneous intracerebral hemorrhage (ICH), in part because of its high case fatality.<sup><xref rid="R2" ref-type="bibr">2</xref>,<xref rid="R3" ref-type="bibr">3</xref></sup> Cognitive impairment often develops in survivors of ICH who were previously dementia free, particularly if the ICH is lobar, and has been associated with baseline neuroimaging markers of cerebral amyloid angiopathy (CAA).<sup><xref rid="R2" ref-type="bibr">2</xref></sup> In those presenting with ICH, cognitive impairment before the event is common, with an estimated pooled incidence of 16.7%,<sup><xref rid="R4" ref-type="bibr">4</xref></sup> suggesting that the underlying neurovascular and neuropathological processes that result in cognitive impairment after ICH might already be present at the time of initial presentation with ICH.<sup><xref rid="R2" ref-type="bibr">2</xref>,<xref rid="R4" ref-type="bibr">4</xref>,<xref rid="R5" ref-type="bibr">5</xref></sup> However, it is not clear to what extent subsequent cognitive impairment after ICH is mediated by direct damage from the index ICH, the effects of recurrent ICH, or the impact of the underlying small vessel disease (SVD)<sup><xref rid="R2" ref-type="bibr">2</xref>,<xref rid="R4" ref-type="bibr">4</xref></sup>; understanding the contribution of these mechanisms is potentially important in developing rational dementia prevention strategies.</p>
            <p>We therefore investigated whether neuroimaging evidence of CAA (specifically, meeting the modified Boston criteria for probable CAA<sup><xref rid="R6" ref-type="bibr">6</xref></sup> at presentation, and increases in a composite CAA score<sup><xref rid="R7" ref-type="bibr">7</xref></sup>) was associated with the presence of cognitive impairment before ICH. We then performed further analyses investigating the associations between individual magnetic resonance imaging (MRI) neuroimaging markers of SVD and cognitive impairment before ICH.</p>
            <sec sec-type="methods">
              <title>Materials and Methods</title>
              <sec sec-type="subjects">
                <title>Patient Selection</title>
                <p>We included patients recruited to a prospective multicentre observational cohort study of symptomatic patients with confirmed ICH (The Clinical Relevance of Microbleeds In Stroke Study; CROMIS-2). Those aged â¥18 years with an ICH confirmed on brain imaging (either computed tomography or MRI) were eligible, providing that there was no evidence that the ICH was because of an underlying structural cause or secondary to head trauma. This study has been preregistered, and the full details of the study protocol have been published previously.<sup><xref rid="R8" ref-type="bibr">8</xref></sup> The study was approved by the National Research Ethics Service (IRAS reference 10/H0716/61). Written informed consent was obtained from each patient. The primary and substudy analyses for the CROMIS-2 study are ongoing; once all of these analyses are completed, the CROMIS-2 Steering Committee will consider applications from other researchers for access to anonymized source data.</p>
                <p>The Informant Questionnaire for Cognitive Decline in the Elderly (IQCODE) is a validated questionnaire given to a patientâs family member or caregiver which aims to establish whether there have been specific changes in cognitive and functional performance over the preceding 10-year time period.<sup><xref rid="R9" ref-type="bibr">9</xref>â<xref rid="R11" ref-type="bibr">11</xref></sup> Specifically, the informant was asked to compare the patientâs performance from 10 years ago with their performance just before their stroke. The 16-item IQCODE was requested for all participants (score range, 1.0â5.0); this version of the IQCODE has been reported to have similar accuracy to the original 26-item version.<sup><xref rid="R10" ref-type="bibr">10</xref></sup> We defined pre-ICH cognitive impairment as an IQCODE score of &gt;3.3, based on previously reported pooled sensitivity and specificity values for detecting cognitive impairment from a meta-analysis investigating IQCODE accuracy in a general hospital setting.<sup><xref rid="R10" ref-type="bibr">10</xref></sup></p>
                <p>For inclusion in the final analysis, it was necessary for patients to have an IQCODE from the time of their admission, together with the MRI sequences needed for imaging analysis (described below).</p>
              </sec>
              <sec>
                <title>Imaging Acquisition and Analysis</title>
                <p>Imaging was undertaken at each study center according to local protocols, and all brain imaging performed as part of the participantâs standard clinical care was sent to the studyâs coordinating center in anonymized DICOM format.</p>
                <p>Imaging analysis was performed by 2 clinical research associates (D.W., G.B.) and 2 MSc students (K.O.-B.A, S.L.), all of whom were trained in neuroimaging rating and blinded to the participant clinical details. All structural imaging markers of cerebral SVD were rated in accordance with the Standards for Reporting Vascular Changes on Neuroimaging consensus criteria.<sup><xref rid="R12" ref-type="bibr">12</xref></sup> Only those with an available MRI and all of the necessary sequences for cerebral SVD rating (ie, axial T2, axial or coronal fluid-attenuated inversion recovery (FLAIR), and a blood-sensitive sequence) were included in the neuroimaging marker analysis.</p>
                <p>Lacunes were identified and counted (D.W.) on T2 and FLAIR sequences.<sup><xref rid="R12" ref-type="bibr">12</xref></sup> Cerebral microbleeds were rated (D.W.) using blood-sensitive (T2* weighted or susceptibility weighted images) sequences and the validated Microbleed Anatomical Rating Scale.<sup><xref rid="R13" ref-type="bibr">13</xref></sup> MRI-visible perivascular spaces (PVS) in the centrum semiovale (CSO-PVS) and basal ganglia (BG-PVS) were defined and rated (G.B.) on T2 and FLAIR sequences using a validated 4-point visual rating scale<sup><xref rid="R12" ref-type="bibr">12</xref>,<xref rid="R14" ref-type="bibr">14</xref>,<xref rid="R15" ref-type="bibr">15</xref></sup>on a single predefined slice (first slice above the anterior commissure for the basal ganglia, and the first slice above the level of the lateral ventricles for the centrum semiovale). The hemisphere contralateral to the ICH was preferentially rated. White matter hyperintensities (WMH; also termed leukoaraiosis) were rated (K.O.-B.A.) on T2 and FLAIR sequences using the Fazekas scale.<sup><xref rid="R16" ref-type="bibr">16</xref>,<xref rid="R17" ref-type="bibr">17</xref></sup> Cortical superficial siderosis (cSS) was identified on blood-sensitive sequences and classified (D.W.) as either focal (involving â¤3 sulci) or disseminated (involving â¥4 sulci), in keeping with previously described terminology.<sup><xref rid="R18" ref-type="bibr">18</xref></sup> Medial temporal atrophy (MTA) was rated (G.B.) on T1 or FLAIR coronal images using the Scheltens visual scale.<sup><xref rid="R19" ref-type="bibr">19</xref>,<xref rid="R20" ref-type="bibr">20</xref></sup> Global cortical atrophy (GCA) was rated (G.B.) using the Pasquier scale on axial T1 or FLAIR images. In cases where these sequences were not available, T2 images were used. For both MTA and GCA, there was good agreement between all sequences used (MTA Îº=0.77; GCA Îº=1.00). For both MTA and GCA, the hemisphere contralateral to the ICH was preferentially rated.</p>
                <p>ICH location was defined as infratentorial, deep, or lobar, with the latter in cortical or corticalâsubcortical regions and not involving any of the deep grey matter structures. Hematoma volume was calculated (S.L.) using a previously described validated semiautomated planimetric method.<sup><xref rid="R21" ref-type="bibr">21</xref></sup></p>
                <p>A clinico-radiological diagnosis of probable CAA was based on meeting the modified Boston criteria.<sup><xref rid="R6" ref-type="bibr">6</xref></sup></p>
                <p>The CAA score was calculated from a previously described 6-point scale.<sup><xref rid="R7" ref-type="bibr">7</xref></sup> This scale awards 1 point for CSO-PVS rating of frequent-to-severe grades (ie, presence of &gt;20 CSO-PVS) and WMH that is either Fazekas grade 3 if periventricular, or Fazekas grade â¥2 if deep.<sup><xref rid="R22" ref-type="bibr">22</xref></sup> Additional points are awarded for the presence of lobar microbleeds (1 point if 2â4 are present; 2 points if there are â¥5) and cSS (1 point if focal; 2 points if disseminated).<sup><xref rid="R7" ref-type="bibr">7</xref></sup></p>
                <p>The SVD score was determined using a previously described 4-point scale.<sup><xref rid="R22" ref-type="bibr">22</xref>,<xref rid="R23" ref-type="bibr">23</xref></sup> This scale awards 1 point for the presence of lacunes, microbleeds, BG-PVS rating of moderate-to-severe grades (ie, presence of &gt;10 BG-PVS), and WMH that is either Fazekas grade 3 if periventricular or Fazekas grade â¥2 if deep.<sup><xref rid="R22" ref-type="bibr">22</xref></sup></p>
              </sec>
              <sec>
                <title>Statistics</title>
                <p>We investigated for selection bias within our final cohort by comparing the characteristics of people with appropriate MRI and those without. IQCODE was dichotomized using a cutoff of 3.3, and baseline characteristics were compared (Table <xref ref-type="table" rid="T1">1</xref>) for those with scores &gt;3.3 (ie, with cognitive impairment) and those with scores â¤3.3. Continuous data were reviewed for normality, and if normally distributed we used the independent <italic>t</italic> test. Where continuous variables were not normally distributed, we used the (nonparametric) MannâWhitney <italic>U</italic> test. We used the Ï<sup>2</sup> tests for categorical variables. The independent <italic>t</italic> test (normally distributed continuous data) and the 2-sample test of proportion (categorical data) were used to compare means and proportions, respectively.</p>
                <table-wrap id="T1" position="float">
                  <label>Table 1.</label>
                  <caption>
                    <p>Baseline Demographic and Clinical Characteristics</p>
                  </caption>
                  <graphic xlink:href="str-49-040-g001"/>
                </table-wrap>
                <p>Univariate comparisons were used to identify potential confounders for inclusion in the multivariable models; all variables with <italic>P</italic>&lt;0.05 were included. We then performed adjusted logistic regression analyses, adjusting for significant associations identified in univariate analyses (Table <xref ref-type="table" rid="T2">2</xref>). In further analyses (Table <xref ref-type="table" rid="T3">3</xref>), we investigated associations with other neuroimaging markers suggestive of CAA (the presence of strictly lobar microbleeds, and presentation with lobar ICH), as well as a composite SVD score and its component elements. In these analyses, each neuroimaging marker was considered individually (ie, each adjusted model included only 1 neuroimaging marker at a time). Given that these analyses were exploratory, we did not make an adjustment for multiple testing.</p>
                <table-wrap id="T2" position="float">
                  <label>Table 2.</label>
                  <caption>
                    <p>Univariable and Adjusted Logistic Regression Models, Investigating Associations Between Cognitive Impairment Before ICH and Evidence of CAA</p>
                  </caption>
                  <graphic xlink:href="str-49-040-g002"/>
                </table-wrap>
                <table-wrap id="T3" position="float">
                  <label>Table 3.</label>
                  <caption>
                    <p>Logistic Regression Models (Univariable and Adjusted), Reviewing Associations Between Cognitive Impairment Before ICH and Individual Structural Markers of Cerebral SVD, and a Composite SVD Score</p>
                  </caption>
                  <graphic xlink:href="str-49-040-g003"/>
                </table-wrap>
                <p>Statistical analysis was performed (G.B.) using Stata (Version 11.2).</p>
              </sec>
            </sec>
            <sec sec-type="results">
              <title>Results</title>
              <sec>
                <title>Cohort Characteristics</title>
                <p>The demographic and imaging characteristics of those included (n=166) are shown in Table <xref ref-type="table" rid="T1">1</xref>. Patients without MRI (n=588) and those with MRI but with missing or uninterpretable sequences (n=43) were excluded (<ext-link ext-link-type="uri" xlink:href="http://stroke.ahajournals.org/lookup/suppl/doi:10.1161/STROKEAHA.117.019409/-/DC1">online-only Data Supplement</ext-link>). When compared with the excluded patients (<ext-link ext-link-type="uri" xlink:href="http://stroke.ahajournals.org/lookup/suppl/doi:10.1161/STROKEAHA.117.019409/-/DC1">online-only Data Supplement</ext-link>), those included were younger (mean, 68.9 versus 75.0 years; <italic>P</italic>&lt;0.00001), less likely to have hypertension (58.2% versus 70.9%; <italic>P</italic>=0.002), hypercholesterolemia (35.8% versus 47.9%; <italic>P</italic>=0.006), diabetes mellitus (12.1% versus 19.8%; <italic>P</italic>=0.024), and atrial fibrillation (12.3% versus 43.5%; <italic>P</italic>&lt;0.0001), and more likely to have previously had an ischemic stroke or transient ischemic attack (24.7% versus 18.1%; <italic>P</italic>=0.081), lower Glasgow Coma Scale at presentation (interquartile range, 13â15 versus 14â15; <italic>P</italic>=0.003) and pre-ICH cognitive decline (38.2% versus 24.7%; <italic>P</italic>=0.001).</p>
                <p>When comparing those with and without pre-ICH cognitive decline, those with (n=41) were older (mean difference, 7.5 years; <italic>P</italic>&lt;0.0012) and more likely to have hypercholesterolemia (51.2% versus 30.6%; <italic>P</italic>=0.017), diabetes mellitus (22.0% versus 8.9%; <italic>P</italic>=0.026), previous ischemic stroke or transient ischemic attack (29.0% versus 14.8%; <italic>P</italic>=0.047), and previous ICH (12.5% versus 3.2%; <italic>P</italic>=0.025).</p>
              </sec>
              <sec>
                <title>Associations With Pre-ICH Cognitive Decline: Univariate and Multivariate Analyses</title>
                <p>Univariate logistic regression analyses showed that pre-ICH cognitive decline was associated with meeting the modified Boston criteria for probable CAA at presentation and increasing CAA score (Table <xref ref-type="table" rid="T2">2</xref>). In our multivariable analysis, we adjusted for age at event, hypercholesterolemia, presence of diabetes mellitus, previous ischemic stroke or transient ischemic attack, and previous ICH, which were statistically significant in univariate analyses (Table <xref ref-type="table" rid="T1">1</xref>). Meeting the modified Boston criteria for probable CAA at presentation (odds ratio [OR], 4.01; 95% confidence interval [CI], 1.53â10.51); <italic>P</italic>=0.005) and increasing CAA score (for each point increase, OR, 1.42; 95% CI, 1.03â1.97; <italic>P</italic>=0.033) remained associated with pre-ICH cognitive decline (Table <xref ref-type="table" rid="T2">2</xref>).</p>
                <p>We then performed further analyses investigating the associations between individual neuroimaging markers of SVD and cognitive impairment before ICH. In univariable analyses (Table <xref ref-type="table" rid="T3">3</xref>), we identified associations between pre-ICH cognitive decline and increasing SVD score, WMH, the presence of cSS, presence of strictly lobar microbleeds, and lobar ICH at presentation. In analyses adjusted for clinical and demographic variables identified in the univariate analysis (as above), the presence of cSS (OR, 4.08; 95% CI, 1.28â13.05; <italic>P</italic>=0.018), strictly lobar microbleeds (OR, 2.47; 95% CI, 0.95â6.37; <italic>P</italic>=0.062), and lobar ICH at presentation (OR, 2.29; 95% CI, 0.99â5.31; <italic>P</italic>=0.053) showed associations with pre-ICH cognitive impairment. The previous associations with increasing SVD score and WMH were no longer statistically significant, although for WMH a large effect size remained (OR, 2.03).</p>
              </sec>
            </sec>
            <sec sec-type="discussion">
              <title>Discussion</title>
              <p>Our main new finding is that MRI neuroimaging markers of CAA are associated with pre-ICH cognitive impairment. This suggests that cognitive impairment in CAA is not only because of brain injury caused directly by ICH but also independently related to the underlying small vessel disruption associated with CAA.</p>
              <p>Our findings add to growing evidence that CAA plays an important role in the development of cognitive impairment and dementia in those with ICH. The prevalence of pre-ICH dementia in lobar ICH is near double that in deep ICH,<sup><xref rid="R24" ref-type="bibr">24</xref></sup> and structural imaging markers of CAA (cSS, cerebral microbleeds) present at the time of ICH are associated with later progression to dementia.<sup><xref rid="R2" ref-type="bibr">2</xref></sup> Our results show that a composite CAA score has a per point association with cognitive decline; further studies could help establish whether such a score might be useful in patients with milder CAA (including those not fulfilling Boston criteria, or without macrohemorrhage). We found a strong association between cSS and pre-ICH cognitive impairment, suggesting that leptomeningeal hemorrhage, rather than parenchymal microbleeds, might be an especially important pathological process impairing cognition in CAA. Our findings also contribute to our understanding of the mechanisms by which CAA disrupts cognition, which include hematoma damage (via direct effects on cortical integrity and function<sup><xref rid="R2" ref-type="bibr">2</xref></sup>) and small vessel mechanisms. The latter may include effects on brain network efficiency,<sup><xref rid="R25" ref-type="bibr">25</xref></sup> which correlates with cognitive performance and shows disturbances in the non-ICH hemisphere.<sup><xref rid="R26" ref-type="bibr">26</xref></sup> Our finding that CAA is associated with cognitive impairment before ICH shows that hematoma damage cannot be the only mechanism contributing to cognitive disruption and supports the hypothesis that small vessel mechanisms are important.</p>
              <p>A further possibility is that cognitive impairment before ICH is because of coincident Alzheimerâs disease.<sup><xref rid="R4" ref-type="bibr">4</xref></sup> Although the co-occurrence of CAA and Alzheimerâs disease pathology is well recognized,<sup><xref rid="R27" ref-type="bibr">27</xref></sup> CAA seems to have a cognitive profile distinct from that seen in Alzheimerâs disease, characterized primarily by deficits in processing speed and executive function.<sup><xref rid="R28" ref-type="bibr">28</xref>,<xref rid="R29" ref-type="bibr">29</xref></sup> Recent neuropathological work<sup><xref rid="R30" ref-type="bibr">30</xref></sup> found that CAA makes an independent contribution to cognitive performance in Alzheimerâs disease. Together, this evidence suggests that CAA has a specific neurovascular impact on cognitive performance, independent of coexistent Alzheimerâs pathology. Although we did not find an association between MTA or GCA (as putative imaging markers of Alzheimerâs pathology<sup><xref rid="R31" ref-type="bibr">31</xref></sup>) and pre-ICH cognitive impairment, we acknowledge that our sample size is small and so we cannot rule out missing subtle effects.</p>
              <p>The main strength of this study is our detailed neuroimaging description of the structural markers of cerebral SVD in the context of pre-ICH cognitive decline, in a richly phenotyped prospective nationwide cohort of patients. However, our work also has limitations. Those included in our study were younger, with fewer comorbidities and a lower IQCODE than those who did not have an interpretable MRI; additionally, we acknowledge that a suspicion of CAA could increase the likelihood of an MRI being performed (50% of our included patients presented with lobar ICH), and so our final cohort might not be representative of those presenting with a spontaneous ICH to an acute stroke service. Brain imaging at each study center was completed according to local protocols, and so there are unavoidable variations in the nature and manner of the sequences obtained, which could influence our results. In particular, the use of susceptibility-weighted versus T2*-weighted gradient echo sequences may result different microbleed counts, as the former is more sensitive to this; we did not adjust for this in our analyses. There are inherent limitations of using the IQCODE, including variations in the threshold used to define cognitive impairment and the lack of validation against a reference standard for prestroke cognitive impairment. Finally, we acknowledge that our study size is small, and so our results should be interpreted cautiously, particularly the adjusted analyses. As detailed, we chose not to apply an adjustment for multiple testing in order not to miss potential associations of interest. In addition, although our study is powered to detect moderate effect sizes, it may have missed smaller effects.</p>
              <p>Cognitive impairment before ICH is common and is associated with imaging findings consistent with an important contribution from CAA. This suggests that any future strategy aiming to reduce the impact of poststroke dementia in ICH will need to extend beyond stroke prevention and include strategies that address the small vessel impact of CAA. Further work on the natural history of when and how CAA may influence an individualâs cognitive profile is a priority for future research.</p>
            </sec>
            <sec>
              <title>Appendix</title>
              <p>The CROMIS-2 Collaborators: Louise Shaw, MD; Jane Sword, MD; Azlisham Mohd Nor, MD; Pankaj Sharma, PhD; Roland Veltkamp MD; Deborah Kelly, MD; Frances Harrington, MD; Marc Randall, MD; Matthew Smith, MD; Karim Mahawish, MD; Abduelbaset Elmarim, MD; Bernard Esisi, MD; Claire Cullen, MD; Arumug Nallasivam, MD; Christopher Price, MD; Adrian Barry, MD; Christine Roffe, MD; John Coyle, MD; Ahamad Hassan, MD; Caroline Lovelock, DPhil; Jonathan Birns, MD; David Cohen, MD; L. Sekaran, MD; Adrian Parry-Jones, PhD; Anthea Parry, MD; David Hargroves, MD; Harald Proschel, MD; Prabel Datta, MD; Khaled Darawil, MD; Aravindakshan Manoj, MD; Mathew Burn, MD; Chris Patterson, MD; Elio Giallombardo, MD; Nigel Smyth, MD; Syed Mansoor, MD; Ijaz Anwar, MD; Rachel Marsh, MD; Sissi Ispoglou, MD; Dinesh Chadha, MD; Mathuri Prabhakaran, MD; Sanjeevikumar Meenakishundaram, MD; Janice OâConnell, MD; Jon Scott, MD; Vinodh Krishnamurthy, MD; Prasanna Aghoram, MD; Michael McCormick, MD; Paul OâMahony, MD; Martin Cooper, MD; Lillian Choy, MD; Peter Wilkinson, MD; Simon Leach, MD; Sarah Caine, MD; Ilse Burger, MD; Gunaratam Gunathilagan, MD; Paul Guyler, MD; Hedley Emsley, MD; Michelle Davis, MD; Dulka Manawadu, MD; Kath Pasco, MD; Maam Mamun, MD; Robert Luder, MD; Mahmud Sajid, MD; Ijaz Anwar, MD; James Okwera, MD; Julie Staals, PhD; Elizabeth Warburton, MD; Kari Saastamoinen, MD; Timothy England, MD; Janet Putterill, MD; Enrico Flossman, MD; Michael Power, MD; Krishna Dani, MD; David Mangion, MD; Appu Suman, MD; John Corrigan, MD; Enas Lawrence, MD; and Djamil Vahidassr, MD.</p>
            </sec>
            <sec>
              <title>Sources of Funding</title>
              <p>The CROMIS-2 study is funded by the Stroke Association and British Heart Foundation. G. Banerjee receives funding from the Rosetrees Trust. Dr Ambler receives funding from the National Institute for Health Research University College London Hospitals Biomedical Research Centre. Dr Al-Shahi Salman is funded by an Medical Research Council senior clinical fellowship. M.M. Brownâs Chair in Stroke Medicine is supported by the Reta Lila Weston Trust for Medical Research. Dr Werring receives research support from the Stroke Association, the British Heart Foundation, and the Rosetrees Trust. This work was undertaken at University College London Hospitals and University College London which receive a proportion of funding from the Department of Health National Institute for Health Research (NIHR) Biomedical Research Centres funding scheme.</p>
            </sec>
            <sec>
              <title>Disclosures</title>
              <p>Dr Cohen has received institutional research support from Bayer; honoraria for lectures and an Advisory Board from Bayer, diverted to a local charity; and travel/accommodation expenses for participation in scientific meetings covered by Bayer and Boehringer Ingelheim. G.H.Y. Lip has served as a consultant for Bayer, Astellas, Merck, AstraZeneca, Sanofi, BMS/Pfizer, Biotronik, Portola, and Boehringer Ingelheim and has been on the speakersâ bureau for Bayer, BMS/Pfizer, Boehringer Ingelheim, and Sanofi-Aventis. The other authors report no conflicts.</p>
            </sec>
            <sec sec-type="supplementary-material">
              <title>Supplementary Material</title>
              <fig id="s1" position="anchor">
                <media xlink:href="str-49-040-s001.pdf"/>
              </fig>
            </sec>
          </body>
          <back>
            <fn-group>
              <fn fn-type="other" id="fn01">
                <p>Continuing medical education (CME) credit is available for this article. Go to <ext-link ext-link-type="uri" xlink:href="http://cme.ahajournals.org">http://cme.ahajournals.org</ext-link> to take the quiz.</p>
              </fn>
              <fn fn-type="other" id="fn02">
                <label>*</label>
                <p>A list of all the CROMIS-2 Collaborators is given in the Appendix.</p>
              </fn>
              <fn fn-type="other" id="fn03">
                <p>The online-only Data Supplement is available with this article at <ext-link ext-link-type="uri" xlink:href="http://stroke.ahajournals.org/lookup/suppl/doi:10.1161/STROKEAHA.117.019409/-/DC1">http://stroke.ahajournals.org/lookup/suppl/doi:10.1161/STROKEAHA.117.019409/-/DC1</ext-link>.</p>
              </fn>
            </fn-group>
            <ref-list>
              <title>References</title>
              <ref id="R1">
                <label>1.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Pendlebury</surname>
                      <given-names>ST</given-names>
                    </name>
                    <name>
                      <surname>Rothwell</surname>
                      <given-names>PM</given-names>
                    </name>
                  </person-group>
                  <article-title>Prevalence, incidence, and factors associated with pre-stroke and post-stroke dementia: a systematic review and meta-analysis.</article-title>
                  <source>Lancet Neurol</source>
                  <year>2009</year>
                  <volume>8</volume>
                  <fpage>1006</fpage>
                  <lpage>1018</lpage>
                  <comment>doi: 10.1016/S1474-4422(09)70236-4.</comment>
                  <pub-id pub-id-type="pmid">19782001</pub-id>
                </element-citation>
              </ref>
              <ref id="R2">
                <label>2.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Moulin</surname>
                      <given-names>S</given-names>
                    </name>
                    <name>
                      <surname>Labreuche</surname>
                      <given-names>J</given-names>
                    </name>
                    <name>
                      <surname>Bombois</surname>
                      <given-names>S</given-names>
                    </name>
                    <name>
                      <surname>Rossi</surname>
                      <given-names>C</given-names>
                    </name>
                    <name>
                      <surname>Boulouis</surname>
                      <given-names>G</given-names>
                    </name>
                    <name>
                      <surname>HÃ©non</surname>
                      <given-names>H</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>Dementia risk after spontaneous intracerebral haemorrhage: a prospective cohort study.</article-title>
                  <source>Lancet Neurol</source>
                  <year>2016</year>
                  <volume>15</volume>
                  <fpage>820</fpage>
                  <lpage>829</lpage>
                  <comment>doi: 10.1016/S1474-4422(16)00130-7.</comment>
                  <pub-id pub-id-type="pmid">27133238</pub-id>
                </element-citation>
              </ref>
              <ref id="R3">
                <label>3.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Poon</surname>
                      <given-names>MT</given-names>
                    </name>
                    <name>
                      <surname>Fonville</surname>
                      <given-names>AF</given-names>
                    </name>
                    <name>
                      <surname>Al-Shahi Salman</surname>
                      <given-names>R</given-names>
                    </name>
                  </person-group>
                  <article-title>Long-term prognosis after intracerebral haemorrhage: systematic review and meta-analysis.</article-title>
                  <source>J Neurol Neurosurg Psychiatry</source>
                  <year>2014</year>
                  <volume>85</volume>
                  <fpage>660</fpage>
                  <lpage>667</lpage>
                  <comment>doi: 10.1136/jnnp-2013-306476.</comment>
                  <pub-id pub-id-type="pmid">24262916</pub-id>
                </element-citation>
              </ref>
              <ref id="R4">
                <label>4.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Xiong</surname>
                      <given-names>L</given-names>
                    </name>
                    <name>
                      <surname>Reijmer</surname>
                      <given-names>YD</given-names>
                    </name>
                    <name>
                      <surname>Charidimou</surname>
                      <given-names>A</given-names>
                    </name>
                    <name>
                      <surname>Cordonnier</surname>
                      <given-names>C</given-names>
                    </name>
                    <name>
                      <surname>Viswanathan</surname>
                      <given-names>A</given-names>
                    </name>
                  </person-group>
                  <article-title>Intracerebral hemorrhage and cognitive impairment.</article-title>
                  <source>Biochim Biophys Acta</source>
                  <year>2016</year>
                  <volume>1862</volume>
                  <fpage>939</fpage>
                  <lpage>944</lpage>
                  <comment>doi: 10.1016/j.bbadis.2015.12.011.</comment>
                  <pub-id pub-id-type="pmid">26692171</pub-id>
                </element-citation>
              </ref>
              <ref id="R5">
                <label>5.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Biffi</surname>
                      <given-names>A</given-names>
                    </name>
                    <name>
                      <surname>Bailey</surname>
                      <given-names>D</given-names>
                    </name>
                    <name>
                      <surname>Anderson</surname>
                      <given-names>CD</given-names>
                    </name>
                    <name>
                      <surname>Ayres</surname>
                      <given-names>AM</given-names>
                    </name>
                    <name>
                      <surname>Gurol</surname>
                      <given-names>EM</given-names>
                    </name>
                    <name>
                      <surname>Greenberg</surname>
                      <given-names>SM</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>Risk factors associated with early vs delayed dementia after intracerebral hemorrhage.</article-title>
                  <source>JAMA Neurol</source>
                  <year>2016</year>
                  <volume>73</volume>
                  <fpage>969</fpage>
                  <lpage>976</lpage>
                  <comment>doi: 10.1001/jamaneurol.2016.0955.</comment>
                  <pub-id pub-id-type="pmid">27295605</pub-id>
                </element-citation>
              </ref>
              <ref id="R6">
                <label>6.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Linn</surname>
                      <given-names>J</given-names>
                    </name>
                    <name>
                      <surname>Halpin</surname>
                      <given-names>A</given-names>
                    </name>
                    <name>
                      <surname>Demaerel</surname>
                      <given-names>P</given-names>
                    </name>
                    <name>
                      <surname>Ruhland</surname>
                      <given-names>J</given-names>
                    </name>
                    <name>
                      <surname>Giese</surname>
                      <given-names>AD</given-names>
                    </name>
                    <name>
                      <surname>Dichgans</surname>
                      <given-names>M</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>Prevalence of superficial siderosis in patients with cerebral amyloid angiopathy.</article-title>
                  <source>Neurology</source>
                  <year>2010</year>
                  <volume>74</volume>
                  <fpage>1346</fpage>
                  <lpage>1350</lpage>
                  <comment>doi: 10.1212/WNL.0b013e3181dad605.</comment>
                  <pub-id pub-id-type="pmid">20421578</pub-id>
                </element-citation>
              </ref>
              <ref id="R7">
                <label>7.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Charidimou</surname>
                      <given-names>A</given-names>
                    </name>
                    <name>
                      <surname>Martinez-Ramirez</surname>
                      <given-names>S</given-names>
                    </name>
                    <name>
                      <surname>Reijmer</surname>
                      <given-names>YD</given-names>
                    </name>
                    <name>
                      <surname>Oliveira-Filho</surname>
                      <given-names>J</given-names>
                    </name>
                    <name>
                      <surname>Lauer</surname>
                      <given-names>A</given-names>
                    </name>
                    <name>
                      <surname>Roongpiboonsopit</surname>
                      <given-names>D</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>Total magnetic resonance imaging burden of small vessel disease in cerebral amyloid angiopathy: an imaging-pathologic study of concept validation.</article-title>
                  <source>JAMA Neurol</source>
                  <year>2016</year>
                  <volume>73</volume>
                  <fpage>994</fpage>
                  <lpage>1001</lpage>
                  <comment>doi: 10.1001/jamaneurol.2016.0832.</comment>
                  <pub-id pub-id-type="pmid">27366898</pub-id>
                </element-citation>
              </ref>
              <ref id="R8">
                <label>8.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Charidimou</surname>
                      <given-names>A</given-names>
                    </name>
                    <name>
                      <surname>Wilson</surname>
                      <given-names>D</given-names>
                    </name>
                    <name>
                      <surname>Shakeshaft</surname>
                      <given-names>C</given-names>
                    </name>
                    <name>
                      <surname>Ambler</surname>
                      <given-names>G</given-names>
                    </name>
                    <name>
                      <surname>White</surname>
                      <given-names>M</given-names>
                    </name>
                    <name>
                      <surname>Cohen</surname>
                      <given-names>H</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>The Clinical Relevance of Microbleeds in Stroke study (CROMIS-2): rationale, design, and methods.</article-title>
                  <source>Int J Stroke</source>
                  <year>2015</year>
                  <volume>10</volume>
                  <issue>suppl A100</issue>
                  <fpage>155</fpage>
                  <lpage>161</lpage>
                  <comment>doi: 10.1111/ijs.12569.</comment>
                  <pub-id pub-id-type="pmid">26235450</pub-id>
                </element-citation>
              </ref>
              <ref id="R9">
                <label>9.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>McGovern</surname>
                      <given-names>A</given-names>
                    </name>
                    <name>
                      <surname>Pendlebury</surname>
                      <given-names>ST</given-names>
                    </name>
                    <name>
                      <surname>Mishra</surname>
                      <given-names>NK</given-names>
                    </name>
                    <name>
                      <surname>Fan</surname>
                      <given-names>Y</given-names>
                    </name>
                    <name>
                      <surname>Quinn</surname>
                      <given-names>TJ</given-names>
                    </name>
                  </person-group>
                  <article-title>Test accuracy of informant-based cognitive screening tests for diagnosis of dementia and multidomain cognitive impairment in stroke.</article-title>
                  <source>Stroke</source>
                  <year>2016</year>
                  <volume>47</volume>
                  <fpage>329</fpage>
                  <lpage>335</lpage>
                  <comment>doi: 10.1161/STROKEAHA.115.011218.</comment>
                  <pub-id pub-id-type="pmid">26683423</pub-id>
                </element-citation>
              </ref>
              <ref id="R10">
                <label>10.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Harrison</surname>
                      <given-names>JK</given-names>
                    </name>
                    <name>
                      <surname>Fearon</surname>
                      <given-names>P</given-names>
                    </name>
                    <name>
                      <surname>Noel-Storr</surname>
                      <given-names>AH</given-names>
                    </name>
                    <name>
                      <surname>McShane</surname>
                      <given-names>R</given-names>
                    </name>
                    <name>
                      <surname>Stott</surname>
                      <given-names>DJ</given-names>
                    </name>
                    <name>
                      <surname>Quinn</surname>
                      <given-names>TJ</given-names>
                    </name>
                  </person-group>
                  <article-title>Informant Questionnaire on Cognitive Decline in the Elderly (IQCODE) for the diagnosis of dementia within a secondary care setting.</article-title>
                  <source>Cochrane Database Syst Rev</source>
                  <year>2015</year>
                  <volume>3</volume>
                  <fpage>CD010772</fpage>
                </element-citation>
              </ref>
              <ref id="R11">
                <label>11.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Jorm</surname>
                      <given-names>AF</given-names>
                    </name>
                  </person-group>
                  <article-title>A short form of the Informant Questionnaire on Cognitive Decline in the Elderly (IQCODE): development and cross-validation.</article-title>
                  <source>Psychol Med</source>
                  <year>1994</year>
                  <volume>24</volume>
                  <fpage>145</fpage>
                  <lpage>153</lpage>
                  <pub-id pub-id-type="pmid">8208879</pub-id>
                </element-citation>
              </ref>
              <ref id="R12">
                <label>12.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Wardlaw</surname>
                      <given-names>JM</given-names>
                    </name>
                    <name>
                      <surname>Smith</surname>
                      <given-names>EE</given-names>
                    </name>
                    <name>
                      <surname>Biessels</surname>
                      <given-names>GJ</given-names>
                    </name>
                    <name>
                      <surname>Cordonnier</surname>
                      <given-names>C</given-names>
                    </name>
                    <name>
                      <surname>Fazekas</surname>
                      <given-names>F</given-names>
                    </name>
                    <name>
                      <surname>Frayne</surname>
                      <given-names>R</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <collab>STandards for ReportIng Vascular changes on nEuroimaging (STRIVE v1)</collab>
                  <article-title>Neuroimaging standards for research into small vessel disease and its contribution to ageing and neurodegeneration.</article-title>
                  <source>Lancet Neurol</source>
                  <year>2013</year>
                  <volume>12</volume>
                  <fpage>822</fpage>
                  <lpage>838</lpage>
                  <comment>doi: 10.1016/S1474-4422(13)70124-8.</comment>
                  <pub-id pub-id-type="pmid">23867200</pub-id>
                </element-citation>
              </ref>
              <ref id="R13">
                <label>13.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Gregoire</surname>
                      <given-names>SM</given-names>
                    </name>
                    <name>
                      <surname>Chaudhary</surname>
                      <given-names>UJ</given-names>
                    </name>
                    <name>
                      <surname>Brown</surname>
                      <given-names>MM</given-names>
                    </name>
                    <name>
                      <surname>Yousry</surname>
                      <given-names>TA</given-names>
                    </name>
                    <name>
                      <surname>Kallis</surname>
                      <given-names>C</given-names>
                    </name>
                    <name>
                      <surname>JÃ¤ger</surname>
                      <given-names>HR</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>The Microbleed Anatomical Rating Scale (MARS): reliability of a tool to map brain microbleeds.</article-title>
                  <source>Neurology</source>
                  <year>2009</year>
                  <volume>73</volume>
                  <fpage>1759</fpage>
                  <lpage>1766</lpage>
                  <comment>doi: 10.1212/WNL.0b013e3181c34a7d.</comment>
                  <pub-id pub-id-type="pmid">19933977</pub-id>
                </element-citation>
              </ref>
              <ref id="R14">
                <label>14.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Doubal</surname>
                      <given-names>FN</given-names>
                    </name>
                    <name>
                      <surname>MacLullich</surname>
                      <given-names>AM</given-names>
                    </name>
                    <name>
                      <surname>Ferguson</surname>
                      <given-names>KJ</given-names>
                    </name>
                    <name>
                      <surname>Dennis</surname>
                      <given-names>MS</given-names>
                    </name>
                    <name>
                      <surname>Wardlaw</surname>
                      <given-names>JM</given-names>
                    </name>
                  </person-group>
                  <article-title>Enlarged perivascular spaces on MRI are a feature of cerebral small vessel disease.</article-title>
                  <source>Stroke</source>
                  <year>2010</year>
                  <volume>41</volume>
                  <fpage>450</fpage>
                  <lpage>454</lpage>
                  <comment>doi: 10.1161/STROKEAHA.109.564914.</comment>
                  <pub-id pub-id-type="pmid">20056930</pub-id>
                </element-citation>
              </ref>
              <ref id="R15">
                <label>15.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Maclullich</surname>
                      <given-names>AM</given-names>
                    </name>
                    <name>
                      <surname>Wardlaw</surname>
                      <given-names>JM</given-names>
                    </name>
                    <name>
                      <surname>Ferguson</surname>
                      <given-names>KJ</given-names>
                    </name>
                    <name>
                      <surname>Starr</surname>
                      <given-names>JM</given-names>
                    </name>
                    <name>
                      <surname>Seckl</surname>
                      <given-names>JR</given-names>
                    </name>
                    <name>
                      <surname>Deary</surname>
                      <given-names>IJ</given-names>
                    </name>
                  </person-group>
                  <article-title>Enlarged perivascular spaces are associated with cognitive function in healthy elderly men.</article-title>
                  <source>J Neurol Neurosurg Psychiatry</source>
                  <year>2004</year>
                  <volume>75</volume>
                  <fpage>1519</fpage>
                  <lpage>1523</lpage>
                  <comment>doi: 10.1136/jnnp.2003.030858.</comment>
                  <pub-id pub-id-type="pmid">15489380</pub-id>
                </element-citation>
              </ref>
              <ref id="R16">
                <label>16.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Fazekas</surname>
                      <given-names>F</given-names>
                    </name>
                    <name>
                      <surname>Chawluk</surname>
                      <given-names>JB</given-names>
                    </name>
                    <name>
                      <surname>Alavi</surname>
                      <given-names>A</given-names>
                    </name>
                    <name>
                      <surname>Hurtig</surname>
                      <given-names>HI</given-names>
                    </name>
                    <name>
                      <surname>Zimmerman</surname>
                      <given-names>RA</given-names>
                    </name>
                  </person-group>
                  <article-title>MR signal abnormalities at 1.5 T in Alzheimerâs dementia and normal aging.</article-title>
                  <source>AJR Am J Roentgenol</source>
                  <year>1987</year>
                  <volume>149</volume>
                  <fpage>351</fpage>
                  <lpage>356</lpage>
                  <comment>doi: 10.2214/ajr.149.2.351.</comment>
                  <pub-id pub-id-type="pmid">3496763</pub-id>
                </element-citation>
              </ref>
              <ref id="R17">
                <label>17.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Fazekas</surname>
                      <given-names>F</given-names>
                    </name>
                    <name>
                      <surname>Kleinert</surname>
                      <given-names>R</given-names>
                    </name>
                    <name>
                      <surname>Offenbacher</surname>
                      <given-names>H</given-names>
                    </name>
                    <name>
                      <surname>Schmidt</surname>
                      <given-names>R</given-names>
                    </name>
                    <name>
                      <surname>Kleinert</surname>
                      <given-names>G</given-names>
                    </name>
                    <name>
                      <surname>Payer</surname>
                      <given-names>F</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>Pathologic correlates of incidental MRI white matter signal hyperintensities.</article-title>
                  <source>Neurology</source>
                  <year>1993</year>
                  <volume>43</volume>
                  <fpage>1683</fpage>
                  <lpage>1689</lpage>
                  <pub-id pub-id-type="pmid">8414012</pub-id>
                </element-citation>
              </ref>
              <ref id="R18">
                <label>18.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Charidimou</surname>
                      <given-names>A</given-names>
                    </name>
                    <name>
                      <surname>Linn</surname>
                      <given-names>J</given-names>
                    </name>
                    <name>
                      <surname>Vernooij</surname>
                      <given-names>MW</given-names>
                    </name>
                    <name>
                      <surname>Opherk</surname>
                      <given-names>C</given-names>
                    </name>
                    <name>
                      <surname>Akoudad</surname>
                      <given-names>S</given-names>
                    </name>
                    <name>
                      <surname>Baron</surname>
                      <given-names>JC</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>Cortical superficial siderosis: detection and clinical significance in cerebral amyloid angiopathy and related conditions.</article-title>
                  <source>Brain</source>
                  <year>2015</year>
                  <volume>138</volume>
                  <issue>pt 8</issue>
                  <fpage>2126</fpage>
                  <lpage>2139</lpage>
                  <comment>doi: 10.1093/brain/awv162.</comment>
                  <pub-id pub-id-type="pmid">26115675</pub-id>
                </element-citation>
              </ref>
              <ref id="R19">
                <label>19.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Harper</surname>
                      <given-names>L</given-names>
                    </name>
                    <name>
                      <surname>Barkhof</surname>
                      <given-names>F</given-names>
                    </name>
                    <name>
                      <surname>Fox</surname>
                      <given-names>NC</given-names>
                    </name>
                    <name>
                      <surname>Schott</surname>
                      <given-names>JM</given-names>
                    </name>
                  </person-group>
                  <article-title>Using visual rating to diagnose dementia: a critical evaluation of MRI atrophy scales.</article-title>
                  <source>J Neurol Neurosurg Psychiatry</source>
                  <year>2015</year>
                  <volume>86</volume>
                  <fpage>1225</fpage>
                  <lpage>1233</lpage>
                  <comment>doi: 10.1136/jnnp-2014-310090.</comment>
                  <pub-id pub-id-type="pmid">25872513</pub-id>
                </element-citation>
              </ref>
              <ref id="R20">
                <label>20.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Kebets</surname>
                      <given-names>V</given-names>
                    </name>
                    <name>
                      <surname>Gregoire</surname>
                      <given-names>SM</given-names>
                    </name>
                    <name>
                      <surname>Charidimou</surname>
                      <given-names>A</given-names>
                    </name>
                    <name>
                      <surname>Barnes</surname>
                      <given-names>J</given-names>
                    </name>
                    <name>
                      <surname>Rantell</surname>
                      <given-names>K</given-names>
                    </name>
                    <name>
                      <surname>Brown</surname>
                      <given-names>MM</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>Prevalence and cognitive impact of medial temporal atrophy in a hospital stroke service: retrospective cohort study.</article-title>
                  <source>Int J Stroke</source>
                  <year>2015</year>
                  <volume>10</volume>
                  <fpage>861</fpage>
                  <lpage>867</lpage>
                  <comment>doi: 10.1111/ijs.12544.</comment>
                  <pub-id pub-id-type="pmid">26043795</pub-id>
                </element-citation>
              </ref>
              <ref id="R21">
                <label>21.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Volbers</surname>
                      <given-names>B</given-names>
                    </name>
                    <name>
                      <surname>Staykov</surname>
                      <given-names>D</given-names>
                    </name>
                    <name>
                      <surname>Wagner</surname>
                      <given-names>I</given-names>
                    </name>
                    <name>
                      <surname>DÃ¶rfler</surname>
                      <given-names>A</given-names>
                    </name>
                    <name>
                      <surname>Saake</surname>
                      <given-names>M</given-names>
                    </name>
                    <name>
                      <surname>Schwab</surname>
                      <given-names>S</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>Semi-automatic volumetric assessment of perihemorrhagic edema with computed tomography.</article-title>
                  <source>Eur J Neurol</source>
                  <year>2011</year>
                  <volume>18</volume>
                  <fpage>1323</fpage>
                  <lpage>1328</lpage>
                  <comment>doi: 10.1111/j.1468-1331.2011.03395.x.</comment>
                  <pub-id pub-id-type="pmid">21457176</pub-id>
                </element-citation>
              </ref>
              <ref id="R22">
                <label>22.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Staals</surname>
                      <given-names>J</given-names>
                    </name>
                    <name>
                      <surname>Makin</surname>
                      <given-names>SD</given-names>
                    </name>
                    <name>
                      <surname>Doubal</surname>
                      <given-names>FN</given-names>
                    </name>
                    <name>
                      <surname>Dennis</surname>
                      <given-names>MS</given-names>
                    </name>
                    <name>
                      <surname>Wardlaw</surname>
                      <given-names>JM</given-names>
                    </name>
                  </person-group>
                  <article-title>Stroke subtype, vascular risk factors, and total MRI brain small-vessel disease burden.</article-title>
                  <source>Neurology</source>
                  <year>2014</year>
                  <volume>83</volume>
                  <fpage>1228</fpage>
                  <lpage>1234</lpage>
                  <comment>doi: 10.1212/WNL.0000000000000837.</comment>
                  <pub-id pub-id-type="pmid">25165388</pub-id>
                </element-citation>
              </ref>
              <ref id="R23">
                <label>23.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Staals</surname>
                      <given-names>J</given-names>
                    </name>
                    <name>
                      <surname>Booth</surname>
                      <given-names>T</given-names>
                    </name>
                    <name>
                      <surname>Morris</surname>
                      <given-names>Z</given-names>
                    </name>
                    <name>
                      <surname>Bastin</surname>
                      <given-names>ME</given-names>
                    </name>
                    <name>
                      <surname>Gow</surname>
                      <given-names>AJ</given-names>
                    </name>
                    <name>
                      <surname>Corley</surname>
                      <given-names>J</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>Total MRI load of cerebral small vessel disease and cognitive ability in older people.</article-title>
                  <source>Neurobiol Aging</source>
                  <year>2015</year>
                  <volume>36</volume>
                  <fpage>2806</fpage>
                  <lpage>2811</lpage>
                  <comment>doi: 10.1016/j.neurobiolaging.2015.06.024.</comment>
                  <pub-id pub-id-type="pmid">26189091</pub-id>
                </element-citation>
              </ref>
              <ref id="R24">
                <label>24.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Cordonnier</surname>
                      <given-names>C</given-names>
                    </name>
                    <name>
                      <surname>Leys</surname>
                      <given-names>D</given-names>
                    </name>
                    <name>
                      <surname>Dumont</surname>
                      <given-names>F</given-names>
                    </name>
                    <name>
                      <surname>Deramecourt</surname>
                      <given-names>V</given-names>
                    </name>
                    <name>
                      <surname>Bordet</surname>
                      <given-names>R</given-names>
                    </name>
                    <name>
                      <surname>Pasquier</surname>
                      <given-names>F</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>What are the causes of pre-existing dementia in patients with intracerebral haemorrhages?</article-title>
                  <source>Brain</source>
                  <year>2010</year>
                  <volume>133</volume>
                  <fpage>3281</fpage>
                  <lpage>3289</lpage>
                  <comment>doi: 10.1093/brain/awq246.</comment>
                  <pub-id pub-id-type="pmid">20852266</pub-id>
                </element-citation>
              </ref>
              <ref id="R25">
                <label>25.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Reijmer</surname>
                      <given-names>YD</given-names>
                    </name>
                    <name>
                      <surname>Fotiadis</surname>
                      <given-names>P</given-names>
                    </name>
                    <name>
                      <surname>Martinez-Ramirez</surname>
                      <given-names>S</given-names>
                    </name>
                    <name>
                      <surname>Salat</surname>
                      <given-names>DH</given-names>
                    </name>
                    <name>
                      <surname>Schultz</surname>
                      <given-names>A</given-names>
                    </name>
                    <name>
                      <surname>Shoamanesh</surname>
                      <given-names>A</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>Structural network alterations and neurological dysfunction in cerebral amyloid angiopathy.</article-title>
                  <source>Brain</source>
                  <year>2015</year>
                  <volume>138</volume>
                  <issue>p</issue>
                  <issue>t 1</issue>
                  <fpage>179</fpage>
                  <lpage>188</lpage>
                  <comment>doi: 10.1093/brain/awu316.</comment>
                  <pub-id pub-id-type="pmid">25367025</pub-id>
                </element-citation>
              </ref>
              <ref id="R26">
                <label>26.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Reijmer</surname>
                      <given-names>YD</given-names>
                    </name>
                    <name>
                      <surname>Fotiadis</surname>
                      <given-names>P</given-names>
                    </name>
                    <name>
                      <surname>Riley</surname>
                      <given-names>GA</given-names>
                    </name>
                    <name>
                      <surname>Xiong</surname>
                      <given-names>L</given-names>
                    </name>
                    <name>
                      <surname>Charidimou</surname>
                      <given-names>A</given-names>
                    </name>
                    <name>
                      <surname>Boulouis</surname>
                      <given-names>G</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>Progression of brain network alterations in cerebral amyloid angiopathy.</article-title>
                  <source>Stroke</source>
                  <year>2016</year>
                  <volume>47</volume>
                  <fpage>2470</fpage>
                  <lpage>2475</lpage>
                  <comment>doi: 10.1161/STROKEAHA.116.014337.</comment>
                  <pub-id pub-id-type="pmid">27576378</pub-id>
                </element-citation>
              </ref>
              <ref id="R27">
                <label>27.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Arvanitakis</surname>
                      <given-names>Z</given-names>
                    </name>
                    <name>
                      <surname>Leurgans</surname>
                      <given-names>SE</given-names>
                    </name>
                    <name>
                      <surname>Wang</surname>
                      <given-names>Z</given-names>
                    </name>
                    <name>
                      <surname>Wilson</surname>
                      <given-names>RS</given-names>
                    </name>
                    <name>
                      <surname>Bennett</surname>
                      <given-names>DA</given-names>
                    </name>
                    <name>
                      <surname>Schneider</surname>
                      <given-names>JA</given-names>
                    </name>
                  </person-group>
                  <article-title>Cerebral amyloid angiopathy pathology and cognitive domains in older persons.</article-title>
                  <source>Ann Neurol</source>
                  <year>2011</year>
                  <volume>69</volume>
                  <fpage>320</fpage>
                  <lpage>327</lpage>
                  <comment>doi: 10.1002/ana.22112.</comment>
                  <pub-id pub-id-type="pmid">21387377</pub-id>
                </element-citation>
              </ref>
              <ref id="R28">
                <label>28.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Case</surname>
                      <given-names>NF</given-names>
                    </name>
                    <name>
                      <surname>Charlton</surname>
                      <given-names>A</given-names>
                    </name>
                    <name>
                      <surname>Zwiers</surname>
                      <given-names>A</given-names>
                    </name>
                    <name>
                      <surname>Batool</surname>
                      <given-names>S</given-names>
                    </name>
                    <name>
                      <surname>McCreary</surname>
                      <given-names>CR</given-names>
                    </name>
                    <name>
                      <surname>Hogan</surname>
                      <given-names>DB</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>Cerebral amyloid angiopathy is associated with executive dysfunction and mild cognitive impairment.</article-title>
                  <source>Stroke</source>
                  <year>2016</year>
                  <volume>47</volume>
                  <fpage>2010</fpage>
                  <lpage>2016</lpage>
                  <comment>doi: 10.1161/STROKEAHA.116.012999.</comment>
                  <pub-id pub-id-type="pmid">27338926</pub-id>
                </element-citation>
              </ref>
              <ref id="R29">
                <label>29.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Xiong</surname>
                      <given-names>L</given-names>
                    </name>
                    <name>
                      <surname>Davidsdottir</surname>
                      <given-names>S</given-names>
                    </name>
                    <name>
                      <surname>Reijmer</surname>
                      <given-names>YD</given-names>
                    </name>
                    <name>
                      <surname>Shoamanesh</surname>
                      <given-names>A</given-names>
                    </name>
                    <name>
                      <surname>Roongpiboonsopit</surname>
                      <given-names>D</given-names>
                    </name>
                    <name>
                      <surname>Thanprasertsuk</surname>
                      <given-names>S</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>Cognitive profile and its association with neuroimaging markers of non-demented cerebral amyloid angiopathy patients in a stroke unit.</article-title>
                  <source>J Alzheimers Dis</source>
                  <year>2016</year>
                  <volume>52</volume>
                  <fpage>171</fpage>
                  <lpage>178</lpage>
                  <comment>doi: 10.3233/JAD-150890.</comment>
                  <pub-id pub-id-type="pmid">27060947</pub-id>
                </element-citation>
              </ref>
              <ref id="R30">
                <label>30.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Boyle</surname>
                      <given-names>PA</given-names>
                    </name>
                    <name>
                      <surname>Yu</surname>
                      <given-names>L</given-names>
                    </name>
                    <name>
                      <surname>Nag</surname>
                      <given-names>S</given-names>
                    </name>
                    <name>
                      <surname>Leurgans</surname>
                      <given-names>S</given-names>
                    </name>
                    <name>
                      <surname>Wilson</surname>
                      <given-names>RS</given-names>
                    </name>
                    <name>
                      <surname>Bennett</surname>
                      <given-names>DA</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>Cerebral amyloid angiopathy and cognitive outcomes in community-based older persons.</article-title>
                  <source>Neurology</source>
                  <year>2015</year>
                  <volume>85</volume>
                  <fpage>1930</fpage>
                  <lpage>1936</lpage>
                  <comment>doi: 10.1212/WNL.0000000000002175.</comment>
                  <pub-id pub-id-type="pmid">26537052</pub-id>
                </element-citation>
              </ref>
              <ref id="R31">
                <label>31.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Harper</surname>
                      <given-names>L</given-names>
                    </name>
                    <name>
                      <surname>Barkhof</surname>
                      <given-names>F</given-names>
                    </name>
                    <name>
                      <surname>Scheltens</surname>
                      <given-names>P</given-names>
                    </name>
                    <name>
                      <surname>Schott</surname>
                      <given-names>JM</given-names>
                    </name>
                    <name>
                      <surname>Fox</surname>
                      <given-names>NC</given-names>
                    </name>
                  </person-group>
                  <article-title>An algorithmic approach to structural imaging in dementia.</article-title>
                  <source>J Neurol Neurosurg Psychiatry</source>
                  <year>2014</year>
                  <volume>85</volume>
                  <fpage>692</fpage>
                  <lpage>698</lpage>
                  <comment>doi: 10.1136/jnnp-2013-306285.</comment>
                  <pub-id pub-id-type="pmid">24133287</pub-id>
                </element-citation>
              </ref>
            </ref-list>
          </back>
        </article>
      </metadata>
    </record>
  </GetRecord>
</OAI-PMH>
